{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:01:56Z","timestamp":1791352916401,"version":"4.3.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.biopsych.2005.05.044","type":"journal-article","created":{"date-parts":[[2005,9,6]],"date-time":"2005-09-06T17:19:34Z","timestamp":1126027174000},"page":"64-74","source":"Crossref","is-referenced-by-count":303,"title":["ERK Phosphorylation and FosB Expression Are Associated with L-DOPA-Induced Dyskinesia in Hemiparkinsonian Mice"],"prefix":"10.1016","volume":"59","author":[{"given":"Nancy","family":"Pav\u00f3n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana B.","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainhoa","family":"Mendialdua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Moratalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2005.05.044_bib1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1006\/nbdi.1999.0259","article-title":"Striatal FosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson\u2019s disease","volume":"6","author":"Andersson","year":"1999","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.biopsych.2005.05.044_bib2","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/S1471-1931(00)00017-3","article-title":"Electrophysiology of dopamine in normal and denervated striatal neurons","volume":"23","author":"Calabresi","year":"2000","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.biopsych.2005.05.044_bib3","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1016\/S1471-1931(00)00026-4","article-title":"Dopamine-receptor stimulation","volume":"23","author":"Calon","year":"2000","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.biopsych.2005.05.044_bib4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/73949","article-title":"A measure of striatal function predicts motor stereotypy","volume":"4","author":"Canales","year":"2000","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.biopsych.2005.05.044_bib5","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1046\/j.1460-9568.1998.00285.x","article-title":"L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA","volume":"10","author":"Cenci","year":"1998","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2005.05.044_bib6","doi-asserted-by":"crossref","first-page":"8506","DOI":"10.1523\/JNEUROSCI.23-24-08506.2003","article-title":"Distint roles of dopamine D1 and D5 receptors in motor activity and striatal synaptic plasticity","volume":"23","author":"Centonze","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2005.05.044_bib7","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1097\/00001756-199412000-00045","article-title":"NMDA receptor blockade reverses motor response alterations induced by levodopa","volume":"5","author":"Engber","year":"1994","journal-title":"Neuroreport"},{"issue":"suppl 1","key":"10.1016\/j.biopsych.2005.05.044_bib8","first-page":"S2","article-title":"The spectrum of levodopa-induced dyskinesias","volume":"47","author":"Fahn","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2005.05.044_bib9","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1523\/JNEUROSCI.22-03-01054.2002","article-title":"Persistent behavioral sensitization to chronic L-DOPA requires A2A adenosine receptors","volume":"22","author":"Fredduzzi","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2005.05.044_bib10","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1523\/JNEUROSCI.22-12-05042.2002","article-title":"D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1\/2\/MAP kinase","volume":"22","author":"Gerfen","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2005.05.044_bib11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.biopsych.2003.08.008","article-title":"Chronic treatment with atypical neuroleptics induces striosomal FosB\/DeltaFosB expression in rats","volume":"55","author":"Grande","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2005.05.044_bib12","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0014-4886(03)00064-5","article-title":"Increased striatal pre-proenkephalin B expression is associated with dyskinesia in Parkinson\u2019s disease","volume":"183","author":"Henry","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1016\/j.biopsych.2005.05.044_bib13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0304-3940(95)11942-P","article-title":"Compartmental organization of calretinin in the rat striatum","volume":"197","author":"Hiroi","year":"1995","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.biopsych.2005.05.044_bib14","doi-asserted-by":"crossref","first-page":"10397","DOI":"10.1073\/pnas.94.19.10397","article-title":"FosB mutant mice","volume":"94","author":"Hiroi","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2005.05.044_bib15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/(SICI)1096-9861(19961007)374:1<70::AID-CNE5>3.0.CO;2-K","article-title":"Atypical and typical neuroleptic treatments induce distinct programs of transcription factor expression in the striatum","volume":"374","author":"Hiroi","year":"1996","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.biopsych.2005.05.044_bib16","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1212\/WNL.62.1_suppl_1.S47","article-title":"Avoidance of dyskinesia","volume":"62","author":"Jenner","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2005.05.044_bib17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0092-8674(04)00115-1","article-title":"Translational control by MAPK signaling in long-term synaptic plasticity and memory","volume":"116","author":"Kelleher","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.biopsych.2005.05.044_bib18","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/brain\/123.7.1365","article-title":"Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson\u2019s disease","volume":"123","author":"Lee","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.biopsych.2005.05.044_bib19","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.0953-816x.2001.01843.x","article-title":"Pharmacological validation of behavioral measures of akinesia and dyskinesia in a rat model of Parkinson\u2019s disease","volume":"15","author":"Lundblad","year":"2002","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2005.05.044_bib20","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.nbd.2004.01.007","article-title":"A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice","volume":"16","author":"Lundblad","year":"2004","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.biopsych.2005.05.044_bib21","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/syn.10291","article-title":"Bilateral subthalamic nucleus lesion reverses L-DOPA-induced motor fluctuations and facilitates dyskinetic movements in hemiparkinsonian rats","volume":"51","author":"Mar\u00edn","year":"2004","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2005.05.044_bib22","first-page":"S32","article-title":"Problems with long-term levodopa therapy for Parkinson\u2019s disease","volume":"17","author":"Marsden","year":"1994","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.biopsych.2005.05.044_bib23","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/nn1143","article-title":"Regulation of gene expression and cocaine reward by CREB and DeltaFosB","volume":"6","author":"McClung","year":"2003","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.biopsych.2005.05.044_bib24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0896-6273(00)80288-3","article-title":"Network-level changes in expression of inducible Fos-Jun proteins in the striatum during chronic cocaine treatment and withdrawal","volume":"17","author":"Moratalla","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2005.05.044_bib25","doi-asserted-by":"crossref","first-page":"14928","DOI":"10.1073\/pnas.93.25.14928","article-title":"Cellular responses to psychomotor stimulant and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptor","volume":"93","author":"Moratalla","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2005.05.044_bib26","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1046\/j.1471-4159.1999.0720682.x","article-title":"Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D1 or D2 receptor agonists","volume":"72","author":"Morissette","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.biopsych.2005.05.044_bib27","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.neuropharm.2004.06.031","article-title":"Molecular mechanisms of drug addiction","volume":"47","author":"Nestler","year":"2004","journal-title":"Neuropharmacol"},{"key":"10.1016\/j.biopsych.2005.05.044_bib28","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1212\/WNL.62.1_suppl_1.S17","article-title":"The origin of motor fluctuations in Parkinson\u2019s disease","volume":"62","author":"Obeso","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2005.05.044_bib29","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S1471-1931(00)00028-8","article-title":"Pathophysiology of the basal ganglia in Parkinson\u2019s disease","volume":"23","author":"Obeso","year":"2000","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.biopsych.2005.05.044_bib30","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00002826-200403000-00003","article-title":"Multicenter, open-label, trial of sarizotan in Parkinson disease patients with levodopa-induced dyskinesias (the SPLENDID Study)","volume":"27","author":"Olanow","year":"2004","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.biopsych.2005.05.044_bib30a","series-title":"The mouse brain in stereotaxic coordinates","author":"Paxinos","year":"1997"},{"key":"10.1016\/j.biopsych.2005.05.044_bib31","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1046\/j.1471-4159.2003.01960.x","article-title":"Effect of subthalamic nucleus or entopeduncular nucleus lesion on levodopa-induced neurochemical changes within the basal ganglia and on levodopa-induced motor alterations in 6-hydroxydopamine-lesioned rats","volume":"86","author":"Perier","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.biopsych.2005.05.044_bib32","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nn1040","article-title":"Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia","volume":"6","author":"Picconi","year":"2003","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.biopsych.2005.05.044_bib33","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1046\/j.1460-9568.2002.02280.x","article-title":"Molecular phenotype of rat striatal neurons expressing the dopamine D5 receptor subtype","volume":"16","author":"Rivera","year":"2002","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2005.05.044_bib34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.0022-3042.2001.00702.x","article-title":"Differential distribution of dopamine D4 receptors in the striosome\/matrix compartments of the striatum","volume":"80","author":"Rivera","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.biopsych.2005.05.044_bib35","doi-asserted-by":"crossref","first-page":"7557","DOI":"10.1523\/JNEUROSCI.1072-04.2004","article-title":"Repetitive behaviors in monkeys are linked to specific striatal activation patterns","volume":"24","author":"Saka","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2005.05.044_bib36","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0306-4522(00)00155-X","article-title":"Co-stimulation of D(1)\/D(5) and D(2) dopamine receptors leads to an increase in c-fos messenger RNA in cholinergic interneurons and a redistribution of c-fos messenger RNA in striatal projection neurons","volume":"98","author":"Svenningsson","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2005.05.044_bib37","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0006-3223(01)01234-3","article-title":"Elevated levels of DeltaFosB and RGS9 in striatum in Parkinson\u2019s disease","volume":"50","author":"Tekumalla","year":"2001","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2005.05.044_bib38","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrn1346","article-title":"MAPK cascade signaling and synaptic plasticity","volume":"5","author":"Thomas","year":"2004","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.biopsych.2005.05.044_bib39","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0306-4522(02)00548-1","article-title":"Effects of oligonucleotide antisense to dopamine D3 receptor mRNA in a rodent model of behavioral sensitization to levodopa","volume":"116","author":"Van Kampen","year":"2003","journal-title":"Neuroscience"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322305007079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322305007079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T12:12:04Z","timestamp":1552997524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322305007079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0006322305007079"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2005.05.044","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}